Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
LIXT
LIXT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
LIXT News
LIXTE Biotechnology Releases Q1 2026 Financial Report
May 14 2026
Newsfilter
LIXTE Biotechnology Partners with IBN to Enhance Cancer Treatment Awareness
Jan 13 2026
Globenewswire
Lixte Biotechnology Secures $4.3 Million Financing for Cancer Treatment Development
Dec 22 2025
Globenewswire
Lixte Biotechnology Secures $4.3 Million in Registered Direct Offering
Dec 18 2025
Newsfilter
LIXTE Acquires Liora Technologies to Advance Cancer Treatment Standards
Nov 25 2025
Newsfilter
Biotech Stocks Surge After Hours: Insider Purchases, Trial Progress, and Strategic Partnerships Drive Growth
Sep 11 2025
NASDAQ.COM
LIXTE Unveils LB-100 at Inaugural Global Conference on Oncogenic Signaling Activation for Cancer Treatment in 24/7 Market News
Aug 27 2025
Yahoo Finance
Around-the-Clock Market Update: LIXTE Aims at Significant Unaddressed Oncology Markets
Aug 25 2025
Newsfilter
24/7 Market Update: LIXTE Biotechnology Focus - Reevaluating the "Excessive Benefits" Approach for LB-100
Aug 19 2025
Newsfilter
24/7 Market Update: LIXTE Biotechnology Focus - Reevaluating the "Excessive Benefits" Approach for LB-100
Aug 19 2025
Yahoo Finance
24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with First Phase 1B/2 Trial Readout Expected in 2H 2025
Aug 15 2025
Yahoo Finance
24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with Multiple Phase 1B/2 Trial Readouts Expected in 2H 2025
Aug 14 2025
Newsfilter
Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.’s $1.5 Million Registered Direct Offering
Jul 09 2025
Globenewswire
Why Apogee Therapeutics Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket
Jul 07 2025
Benzinga
Dow Jumps Over 200 Points; US Nonfarm Payrolls Beat Estimates
Jul 03 2025
Benzinga
Lixte Biotechnology Holdings, Inc. Announces the Closing of $5.0 Million Private Placement Priced at the Market
Jul 02 2025
Newsfilter
Show More News
